Typically, those taking GLP-1 agonists see an improvement in cardiovascular and metabolic health, with improved blood pressure, decreased LDL cholesterol, and lower risk heart disease
et al., Glucagon-like peptide-1, glucose homeostasis and diabetes
Work through the full tirzepatide dosing guide or semaglutide dosing protocol before considering a drug holiday
For pancreatitis survivors, this transparent, personalized approachrather than a one-size-fits-all commercial modelensures your treatment aligns with your unique risk profile and clinical history
Common adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, and constipation, which typically diminish over time